Skip to content Skip to footer

Decoding the Success and Challenges of Infection Control Efforts in U.S Hospitals: An Analysis of Ongoing Initiatives

The recent prolonged hospitalization of U.S Defense Secretary, Lloyd Austin, due to an infection post prostate cancer surgery made headlines, but it also digs deeper into the ongoing national effort to diminish the prevalence of healthcare-associated infections (HAIs). Though the Centers for Disease Control and Prevention (CDC) label HAIs prevention a ‘top priority’, there’s mystery wrapped around the actual extent of performance in this area due to scant up-to-date data. The last extensive survey discerning HAI prevalence specifically was done in 2015. This gap, though partly blamed on the COVID-19 pandemic, raises eyebrows over the commitment to HAI prevention.

Secretary Austin’s infection was reportedly caused by a urine leak—a rare, but recognized surgical complication. More common are catheter-associated urinary tract infections (CAUTIs), which are among the seven infection types monitored by the CDC in its infection-reduction endeavor. However, CDC’s annual report has shown inconsistency in providing critical information concerning the success or failure of this initiative.

Let’s take a closer look at CAUTIs, which impact nearly half a million patients each year. The CDC reported a 12% decrease in these cases between 2021 and 2022. But viewing this progress in isolation is similar to a mutual fund bragging about its most recent year’s performance. A broader temporal lens is needed to paint the complete picture.

On scrutinizing the CDC’s aggregated data over seven years, a different narrative emerges. Debra Houry, now chief medical officer of the CDC, admitted at a November 2022 patient safety meeting that the pandemic had led to ‘years of progress lost.’ Hospital infections caused by the potentially lethal C. difficile bacteria fell by 52%— a commendable achievement. On the contrary, CAUTIs, despite the mentioned 12% drop from 2021 to 2022, managed a cumulative decrease of merely 30% over seven years. Even grimmer was the 5% decline in surgical site infections post abdominal hysterectomies across seven years. And vent-related events, were 19% higher compared to seven years ago—likely due to COVID-19 related complications.

Central-line associated bloodstream infections deserve special attention. These dangerous and expensive infections saw a 16% drop over seven years. However, a 2006 study published in the New England Journal of Medicine showed even better results—a consortium of 108 Michigan hospitals reduced these infections drastically within three months.

Transparency remains a significant obstacle when gauging progress in infection control. Measures such as the “Standardized Infection Ratio,” used by the CDC. while comparing the ‘expected’ to the ‘actual’ rate of infection, add complexity and ambiguity to the comprehension of real-world infection rates.

Managing and reducing infections requires strict adherence to clinical protocols and robust problem-solving skills. Infection control professionals operate on the frontlines of patient care, and as per the Association for Professionals in Infection Control and Epidemiology, they often feel unappreciated. Consequently, this association has launched an online calculator to evaluate staffing levels, using an algorithm that scrutinizes medical literature to support infection control leaders to fight against chronic understaffing.

Despite the ambitious goal of ‘zero harm’ pledged by many hospital groups, the need for a national patient safety strategy that embraces radical transparency remains unaddressed. Definitive, timely proof that patient outcomes align with such lofty pledges is essential to foster trust in our healthcare system.


Sign Up to Our Newsletter

Be the first to know the latest updates

[yikes-mailchimp form="1"]